Evanson Jeff

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$73,411.28
Insider Sells Quantity
6
Insider Sells Sum
$663,237.72

Insider Activity of Evanson Jeff

According to the SEC Form 4 filings, Evanson Jeff, being in a position of

  1. CHIEF COMMERCIAL OFFICER at Outlook Therapeutics, Inc.,
    оver the last 12 months, has bought 62484 shares for $26,243, and sold 0 shares,
    over all time since 2021-02-12, has bought 97684 shares for $73,411, and sold 496682 shares for $663,238.

The largest purchase of all time was on 2021-12-03 and amounted to 35200 shares of Outlook Therapeutics, Inc. for $47,168.

The largest sale of all time was on 2023-01-20 and amounted to 267000 shares of Outlook Therapeutics, Inc. for $296,370.

Biography of Evanson Jeff

No biography is available at this moment.

2024-03-07PurchaseOutlook Therapeutics, Inc.
OTLK
CHIEF COMMERCIAL OFFICER
62,484
0.0245%
$0.42$26,243-8.63%
2023-01-20SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
267,000
0.1196%
$1.11$296,370-0.92%
2023-01-19SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
103,255
0.0462%
$1.22$125,971-10%
2023-01-18SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
33,738
0.015%
$1.25$42,173-12.9%
2023-01-17SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
27,162
0.0122%
$1.31$35,582-15.63%
2021-12-03PurchaseOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
35,200
0.0188%
$1.34$47,168-6.01%
2021-02-23SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
8,554
0.0056%
$2.09$17,861+2.36%
2021-02-12SaleOutlook Therapeutics, Inc.
OTLK
Chief Commercial Officer
56,973
0.0381%
$2.55$145,281-13.04%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.